Lentiviral vector for the treatment of fanconi anemia

Ended Project Grant Awarded Last action

Award ID
R42HL099150
Recipient
Awarding agency
Obligated
$716,476

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $857,021.76 Federal
  • -$140,545.62 Non-federal
Place of performance
Indianapolis, IN 46202, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$140,546 $0
Amendment -$140,546 $0
Amendment Lentiviral vector for the treatment of fanconi anemia - description (provided by applicant): in this phase II sttr application rimedion seeks to commercialize a… -$140,546 -$140,546
Amendment $0 $0
Amendment $295,259 $0
Amendment $0 $0
Amendment $293,257 $0
Original award $690,143 $0

Quick answers

Who received award R42HL099150?

R42HL099150 was awarded to Rimedion Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2010.

How much is award R42HL099150 worth?

$716,476 has been obligated on R42HL099150: $857,022 in federal funding and -$140,546 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award